SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency

Y Li, MC Choudhary, J Regan, J Boucau… - Science translational …, 2024 - science.org
Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for
prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the …

SARS-CoV-2 drug resistance and therapeutic approaches

S Batool, S Chokkakula, JH Jeong, YH Baek, MS Song - Heliyon, 2025 - cell.com
In light of the transition of COVID-19 from a pandemic to an endemic phase, there is still a
dire need to address challenges associated with drug resistance, particularly among …

RCoV19: a one-stop hub for SARS-CoV-2 genome data integration, variant monitoring, and risk pre-warning

C Li, L Ma, D Zou, R Zhang, X Bai, L Li… - Genomics …, 2023 - academic.oup.com
Abstract The Resource for Coronavirus 2019 (RCoV19) is an open-access information
resource dedicated to providing valuable data on the genomes, mutations, and variants of …

Viralvar: a web tool for multilevel visualization of SARS-CoV-2 genomes

A Alisoltani, L Jaroszewski, A Godzik, A Iranzadeh… - Viruses, 2022 - mdpi.com
The unprecedented growth of publicly available SARS-CoV-2 genome sequence data has
increased the demand for effective and accessible SARS-CoV-2 data analysis and …

Molecular epidemiology of SARS-CoV-2 omicron sub-lineages isolated from Turkish patients infected with COVID-19

M Sayan, A Arikan, E Sanlidag - Viruses, 2023 - mdpi.com
Early detection and characterization of new variants and their impacts enable improved
genomic surveillance. This study aims to evaluate the subvariant distribution of Omicron …

Alterations of SARS-CoV-2 Evolutionary Dynamics by Pharmaceutical Factors

M Halma - Infectious Diseases & Immunity, 2024 - journals.lww.com
The outbreak of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has been
influenced by the human response to the virus. These responses have undoubtedly …

[HTML][HTML] Проблема лекарственной устойчивости вируса SARS-CoV-2 к препаратам прямого противовирусного действия

ЕЛ Гасич, ЕН Кроткова, АД Коско… - БИОпрепараты …, 2024 - cyberleninka.ru
ВВЕДЕНИЕ. Геном SARS-CoV-2 характеризуется высокой частотой мутаций, в связи с
чем особое беспокойство вызывает проблема резистентности вируса к современным …